Understand the source comparison
Sermorelin SubQ vs IM Injection Route: Clinical Comparison
We mean this sincerely: the route doesn't change the peptide's mechanism. Sermorelin binds to GHRH receptors on anterior pituitary somatotrophs regardless of how it entered your bloodstream. What changes is the practical execution. Subcutaneous (SubQ) 27–30G,
No winner is assigned.
This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.
- We mean this sincerely: the route doesn't change the peptide's mechanism. Sermorelin binds to GHRH receptors on anterior pituitary somatotrophs regardless of how it entered your bloodstream. What changes is the practical execution.
- Subcutaneous (SubQ)
- 27–30G, 0.5 inch, 45° angle
- 35–50 minutes
- 85–90%
- Abdomen, thigh, upper arm, lateral hip
- Minimal. Adipose layer regenerates quickly
- Preferred for daily protocols; lower pain, easier self-admin, no anatomical risk
- Intramuscular (IM)
- 22–25G, 1–1.5 inch, 90° angle
- 20–35 minutes
- 88–93%
- Deltoid, vastus lateralis, ventrogluteal, dorsogluteal
- Higher. Muscle fascia scarring over repeated use
- Marginally faster Tmax; higher skill requirement, nerve/vessel proximity risk
- IV (Not Standard)
- 21–23G catheter
- Immediate (bolus)
- 100% (by definition)
- Peripheral vein (AC fossa, hand)
- Highest. Vein trauma, phlebitis risk
- Clinically unnecessary for sermorelin; reserved for hospital GH stim tests